This is consistent with downregulation of PAF1, following KDM4A KD at the transcript (Fig. 3C and D) and protein (Fig. S4A) level in human MLLr-AML cell lines, and primary patient blasts. The gene discussed is KDM4A; the disease is acute myeloid leukemia.